Literature DB >> 18458839

Functional dyspepsia: past, present, and future.

Brecht Geeraerts1, Jan Tack.   

Abstract

Functional dyspepsia (FD) is a highly prevalent gastrointestinal disorder characterized by symptoms originating from the gastroduodenal region in the absence of underlying organic disease that readily explains the symptoms. The Rome II consensus, which defined FD as the presence of unexplained pain or discomfort in the epigastrium, had a number of drawbacks, including an unjustified focus on pain, inclusion of a large number of nonspecific symptoms, and an unclear position on overlap with gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS). The Rome III consensus redefined FD as the presence of epigastric pain or burning, postprandial fullness or early satiation in the absence of underlying organic disease. Frequent overlap with GERD and IBS is acknowledged but does not exclude a diagnosis of FD. A subgroup classification into postprandial distress syndrome and epigastric pain syndrome was proposed. Ongoing studies will clarify the impact of this subdivision on clinical management and treatment outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18458839     DOI: 10.1007/s00535-008-2167-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   6.772


  26 in total

Review 1.  Eradication of Helicobacter pylori for non-ulcer dyspepsia.

Authors:  P Moayyedi; S Soo; J Deeks; B Delaney; A Harris; M Innes; R Oakes; S Wilson; A Roalfe; C Bennett; D Forman
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  Factor analysis of bowel symptoms in US and Italian populations.

Authors:  W E Whitehead; G Bassotti; O Palsson; E Taub; E C Cook; D A Drossman
Journal:  Dig Liver Dis       Date:  2003-11       Impact factor: 4.088

Review 3.  Definition and investigation of dyspepsia. Consensus of an international ad hoc working party.

Authors:  L Barbara; M Camilleri; R Corinaldesi; G P Crean; R C Heading; A G Johnson; J R Malagelada; V Stanghellini; M Wienbeck
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

4.  Functional dyspepsia, delayed gastric emptying, and impaired quality of life.

Authors:  N J Talley; G R Locke; B D Lahr; A R Zinsmeister; G Tougas; G Ligozio; M A Rojavin; J Tack
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

5.  Management of dyspepsia: report of a working party.

Authors: 
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

Review 6.  Review Article: pain versus discomfort--is differentiation clinically useful?

Authors:  V Stanghellini
Journal:  Aliment Pharmacol Ther       Date:  2001-02       Impact factor: 8.171

Review 7.  The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis.

Authors:  Paul Moayyedi; Brendan C Delaney; Nimish Vakil; David Forman; Nicholas J Talley
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 8.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

9.  The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease.

Authors:  R Carlsson; J Dent; E Bolling-Sternevald; F Johnsson; O Junghard; K Lauritsen; S Riley; L Lundell
Journal:  Scand J Gastroenterol       Date:  1998-10       Impact factor: 2.423

10.  Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.

Authors:  David A Peura; Thomas O G Kovacs; David C Metz; Nancy Siepman; Betsy L Pilmer; Nicholas J Talley
Journal:  Am J Med       Date:  2004-06-01       Impact factor: 4.965

View more
  21 in total

Review 1.  Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting.

Authors:  H P Parkman; M Camilleri; G Farrugia; R W McCallum; A E Bharucha; E A Mayer; J F Tack; R Spiller; M Horowitz; A I Vinik; J J Galligan; P J Pasricha; B Kuo; L A Szarka; L Marciani; K Jones; C R Parrish; P Sandroni; T Abell; T Ordog; W Hasler; K L Koch; K Sanders; N J Norton; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2009-12-09       Impact factor: 3.598

2.  Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan.

Authors:  Toshikatsu Okumura; Sachie Tanno; Masumi Ohhira; Satoshi Tanno
Journal:  J Gastroenterol       Date:  2009-12-08       Impact factor: 7.527

3.  Classification of functional dyspepsia based on concomitant bowel symptoms.

Authors:  J Matsuzaki; H Suzuki; K Asakura; Y Fukushima; J M Inadomi; T Takebayashi; T Hibi
Journal:  Neurogastroenterol Motil       Date:  2012-01-11       Impact factor: 3.598

4.  Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?

Authors:  Yao-Chun Hsu; Jyh-Ming Liou; Tzeng-Huey Yang; Wei-Lun Hsu; Hwai-Jeng Lin; Huei-Tang Wu; Jaw-Town Lin; Hsiu-Po Wang; Ming-Shiang Wu
Journal:  J Gastroenterol       Date:  2010-10-19       Impact factor: 7.527

5.  Effect of domperidone therapy on nocturnal dyspeptic symptoms of functional dyspepsia patients.

Authors:  Sheng-Liang Chen; Jie-Ru Ji; Ping Xu; Zhi-Jun Cao; Jian-Zhong Mo; Jing-Yuan Fang; Shu-Dong Xiao
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

6.  Association of genetic variants in GNβ3 with functional dyspepsia: a meta-analysis.

Authors:  Fei Dai; Yaping Liu; Haitao Shi; Shuqiong Ge; Jun Song; Lei Dong; Jingyun Yang
Journal:  Dig Dis Sci       Date:  2014-02-21       Impact factor: 3.199

Review 7.  Helicobacter pylori infection in functional dyspepsia.

Authors:  Hidekazu Suzuki; Paul Moayyedi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

8.  Anxiety and depression are associated with increased counts and degranulation of duodenal mast cells in functional dyspepsia.

Authors:  Hai-Peng Yuan; Zhen Li; Youcan Zhang; Xiao-Pei Li; Fu-Kang Li; Yan-Qing Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  Ecabet sodium induces neuronal nitric oxide synthase-derived nitric oxide synthesis and gastric adaptive relaxation in the human stomach.

Authors:  Yoshiaki Matsumoto; Masanori Ito; Masataka Tsuge; Taiji Matsuo; Shinji Tanaka; Ken Haruma; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2009-08-15       Impact factor: 7.527

10.  The effect of Acid-reducing pharmacotherapy on the severity of nausea and vomiting of pregnancy.

Authors:  Simerpal Kaur Gill; Caroline Maltepe; Katayoon Mastali; Gideon Koren
Journal:  Obstet Gynecol Int       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.